← 返回

探索三维前沿:MSC 球体研究进展及其对乳腺癌与个性化再生治疗的启示

英文原题:Exploring the Three-Dimensional Frontier: Advancements in MSC Spheroids and Their Implications for Breast Cancer and Personalized Regenerative Therapies.

查看英文原题

Exploring the Three-Dimensional Frontier: Advancements in MSC Spheroids and Their Implications for Breast Cancer and Personalized Regenerative Therapies.

PubMed 2023/12/25(内容时间) Biomedicines Q2 · IF 4.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

为了更准确地模拟体内三维(3D)间充质干细胞(MSC)微环境并增强细胞表型以实现更优的体内治疗,通过体外3D培养方法对MSC进行功能化已引起关注。MSC在3D球体中组织化导致细胞形态改变、细胞骨架重排和极化。研究表明,MSC球体内部区域的适度缺氧对MSC的存活和分泌能力产生积极影响。球体缺氧微环境增强血管生成和抗凋亡分子的产生,包括HGF、VEGF和FGF-2。此外,它上调缺氧适应分子如CXCL12和HIF-1的表达,抑制MSC死亡。本综述聚焦于三维MSC系统基础与转化研究的最新进展。这一重点延伸至MSC球体的主要优势和潜在应用,特别是在乳腺癌和定制再生治疗的背景下。

展开英文摘要原文

To more accurately replicate the in vivo three-dimensional (3D) mesenchymal stem cell (MSC) niche and enhance cellular phenotypes for superior in vivo treatments, MSC functionalization through in vitro 3D culture approaches has gained attention. The organization of MSCs in 3D spheroids results in altered cell shape, cytoskeleton rearrangement, and polarization.

Investigations have revealed that the survival and secretory capability of MSCs are positively impacted by moderate hypoxia within the inner zones of MSC spheroids. The spheroid hypoxic microenvironment enhances the production of angiogenic and anti-apoptotic molecules, including HGF, VEGF, and FGF-2.

Furthermore, it upregulates the expression of hypoxia-adaptive molecules such as CXCL12 and HIF-1, inhibiting MSC death. The current review focuses on the latest developments in fundamental and translational research concerning three-dimensional MSC systems. This emphasis extends to the primary benefits and potential applications of MSC spheroids, particularly in the context of breast cancer and customized regenerative therapies.

论文信息

作者
Smolinska V、Harsanyi S、Bohac M、Danisovic L
单位
Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia.
文献类型
综述
期刊
Biomedicines2023 Dec 25
原文标识
PubMed 38255159 · DOI 10.3390/biomedicines12010052